This is where I left off yesterday: Richard Peste
Post# of 155375
(Total Views: 512)
Posted On: 05/25/2022 8:52:27 PM
This is where I left off yesterday:
The statement above stands. He acquires zero direct control, no board seat. CEO is off limits. Within the next 3 years, he will purchase 7 million CYDY shares at $0.37, he still buys these shares and more than likely will make a killing when he sells them. After purchase, he places them into his account which reduces the available outstanding shares keeping them from being sold short. He happily received this olive branch and even takes it upon himself to pay his own attorneys.
What was CytoDyn's incentive? Someone found out that denying him of his claim was not worth anything to CYDY, but giving him back his Prostate test and 8.3 million shares + warrant to buy another 7 million shares at $0.37 was worth far more to CytoDyn than making him lose entirely. That does not mean he receives control. May it never be.
As I see it, this olive branch should protect CytoDyn going forward. We have seen through 13D demonstration, that RP is capable of much wrath. Has CytoDyn tamed the beast? Better yet, has CytoDyn recruited a powerhouse in CCR5 research and understanding, a man respected by BioPharmaceuticals worldwide, with numerous connections in numerous fields, and a man well known to be pro-CytoDyn, pro-leronlimab, pro-CCR5 immunomodulation? Our board understood his potential.
Who does RP bring with him? 13D? I think not. I think many in that camp will be implicated. Amarex arbitration requires answers and RP may give them up now. Maybe the innocent of the 13d pack want what RP got. Maybe they want warrants. Do they offer CytoDyn what RP does? Not in the slightest.
With the extension of this olive branch, could CytoDyn have thwarted another war which otherwise would have smoldered hotter and hotter into realization? CytoDyn effectively threw water on the hot embers and turned them into building blocks upon which it will build its foundation.
We are just getting started...
There is far more to this than what meets the eye.
Things are about to get very interesting and kicked up a few notches.
Quote:
Richard Pestell will not be CytoDyn's new CEO. He will however be CytoDyn's liaison in winning combination therapy partnerships with multiple Big Pharmaceuticals to broaden, strengthen and fortify the indications of their concluding monotherapy drugs for new use as combination therapy with Leronlimab. He will make amends and reap far greater rewards from his host in its rise than he ever has in its fall.
The statement above stands. He acquires zero direct control, no board seat. CEO is off limits. Within the next 3 years, he will purchase 7 million CYDY shares at $0.37, he still buys these shares and more than likely will make a killing when he sells them. After purchase, he places them into his account which reduces the available outstanding shares keeping them from being sold short. He happily received this olive branch and even takes it upon himself to pay his own attorneys.
What was CytoDyn's incentive? Someone found out that denying him of his claim was not worth anything to CYDY, but giving him back his Prostate test and 8.3 million shares + warrant to buy another 7 million shares at $0.37 was worth far more to CytoDyn than making him lose entirely. That does not mean he receives control. May it never be.
As I see it, this olive branch should protect CytoDyn going forward. We have seen through 13D demonstration, that RP is capable of much wrath. Has CytoDyn tamed the beast? Better yet, has CytoDyn recruited a powerhouse in CCR5 research and understanding, a man respected by BioPharmaceuticals worldwide, with numerous connections in numerous fields, and a man well known to be pro-CytoDyn, pro-leronlimab, pro-CCR5 immunomodulation? Our board understood his potential.
Who does RP bring with him? 13D? I think not. I think many in that camp will be implicated. Amarex arbitration requires answers and RP may give them up now. Maybe the innocent of the 13d pack want what RP got. Maybe they want warrants. Do they offer CytoDyn what RP does? Not in the slightest.
With the extension of this olive branch, could CytoDyn have thwarted another war which otherwise would have smoldered hotter and hotter into realization? CytoDyn effectively threw water on the hot embers and turned them into building blocks upon which it will build its foundation.
We are just getting started...
There is far more to this than what meets the eye.
Things are about to get very interesting and kicked up a few notches.
(3)
(0)